Yasumi Uchida1, Yasuto Uchida2, Takanobu Kobayashi3, Seiichiro Shirai4, Nobuyuki Hiruta5, Ei Shimoyama6, Tsuyoshi Tabata7. 1. Japan Foundation for Cardiovascular Research. 2. Department of Cardiology, Tsukuba Memorial Hospital. 3. Department of Cardiology, Chiba-Kensei Hospital. 4. Department of Cardiology, Funabashi-Futawa Hospital. 5. Department of Pathology, Toho University Medical Center Sakura Hospital. 6. Department of Pathology, Funabashi-Futawa Hospital. 7. Department of Clinical Physiology, Toho University Medical Center Sakura Hospital.
Abstract
BACKGROUND: The presence of ceramide in human coronary plaques is a risk factor for ischemic heart disease, but its visualization in the human vessel wall is currently beyond the scope of any available imaging techniques.Methods and Results: Deposition of ceramide was examined by fluorescent angioscopy (FA) and microscopy (FM) using golden fluorescence (Go) as a specific marker of ceramide in yellow plaques, which were obtained from 23 autopsy subjects and classified by conventional angioscopy and histology. Ceramide was observed by FM in 34 of the 41 yellow plaques with a necrotic core (NC) but rarely in the 28 without. Ceramide and macrophages/foam cells co-deposited mainly in the border zone of the NC and fibrous cap (FC). The Go of ceramide was seen when the fibrous cap thickness was ≤100 µm. FA was performed to detect coronary plaques exhibiting Go in patients with coronary artery disease. Ceramide was also detected by FA in 6 of 18 yellow plaques (33.3%) in 8 patients with stable angina and in 18 of 24 yellow plaques (75.0%, P<0.05 vs. stable angina) in 8 patients with old myocardial infarction. CONCLUSIONS: The Go of ceramide in human coronary plaques is detectable by FA and Go could be used as a marker of vulnerable plaque (i.e., thin FC with NC).
BACKGROUND: The presence of ceramide in human coronary plaques is a risk factor for ischemic heart disease, but its visualization in the human vessel wall is currently beyond the scope of any available imaging techniques.Methods and Results: Deposition of ceramide was examined by fluorescent angioscopy (FA) and microscopy (FM) using golden fluorescence (Go) as a specific marker of ceramide in yellow plaques, which were obtained from 23 autopsy subjects and classified by conventional angioscopy and histology. Ceramide was observed by FM in 34 of the 41 yellow plaques with a necrotic core (NC) but rarely in the 28 without. Ceramide and macrophages/foam cells co-deposited mainly in the border zone of the NC and fibrous cap (FC). The Go of ceramide was seen when the fibrous cap thickness was ≤100 µm. FA was performed to detect coronary plaques exhibiting Go in patients with coronary artery disease. Ceramide was also detected by FA in 6 of 18 yellow plaques (33.3%) in 8 patients with stable angina and in 18 of 24 yellow plaques (75.0%, P<0.05 vs. stable angina) in 8 patients with old myocardial infarction. CONCLUSIONS: The Go of ceramide in human coronary plaques is detectable by FA and Go could be used as a marker of vulnerable plaque (i.e., thin FC with NC).
Entities:
Keywords:
Ceramide; Color fluorescent angioscopy; Golden fluorescence; Macrophages; Vulnerable coronary plaque
Authors: Wei Zhao; Xueyin Wang; Amy A Deik; David B Hanna; Tao Wang; Sabina A Haberlen; Sanjiv J Shah; Jason M Lazar; Howard N Hodis; Alan L Landay; Bing Yu; Deborah Gustafson; Kathryn Anastos; Wendy S Post; Clary B Clish; Robert C Kaplan; Qibin Qi Journal: Circulation Date: 2019-04-23 Impact factor: 39.918
Authors: Mika Hilvo; Vlad C Vasile; Leslie J Donato; Reini Hurme; Reijo Laaksonen Journal: Front Endocrinol (Lausanne) Date: 2020-09-29 Impact factor: 5.555
Authors: Mirthe Muilwijk; Nardie Callender; Susan Goorden; Frédéric M Vaz; Irene G M van Valkengoed Journal: Biol Sex Differ Date: 2021-01-13 Impact factor: 5.027
Authors: Parco Chan; Mahwesh Saleem; Nathan Herrmann; Michelle M Mielke; Norman J Haughey; Paul I Oh; Alexander Kiss; Krista L Lanctôt Journal: J Alzheimers Dis Date: 2018 Impact factor: 4.160